News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19

Publish date: December 22, 2021

 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

12 state boards have disciplined docs for COVID misinformation
MDedge ObGyn
Booster recommendations for pregnant women, teens, and other groups explained
MDedge ObGyn
COVID-19 asymptomatic infection rate remains high
MDedge ObGyn
Even COVID-19 can’t stop a true optimist
MDedge ObGyn
FDA updates risks, cautions for clotting-bleeding disorder on Janssen COVID-19 vaccine
MDedge ObGyn
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
MDedge ObGyn
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
MDedge ObGyn
COVID cases spike as questions remain about Omicron’s threat
MDedge ObGyn
Axilla swelling after COVID booster puts focus on mammogram timing
MDedge ObGyn
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
MDedge ObGyn